(18)F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis

Powell Perng1, Charles Marcus1, Rathan M Subramaniam1,2,3,4

  • 11 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287.

Summary

¹⁸F-FDG PET/CT aids in staging melanoma, assessing treatment effectiveness, and predicting patient prognosis. This imaging technique is valuable for managing advanced melanoma patients receiving novel therapies.

Related Concept Videos